A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination

Published:2016-07 Issue:7 Volume:22 Page:483-485
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Kantarci Fatma Eda Nuhoglu,Eren Rafet,Gündoğan Cihan,Huq Gülben Erdem,Doğu Mehmet Hilmi,Suyanı Elif

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference9 articles.

1. Castleman's disease: from basic mechanisms to molecular therapeutics;El-Osta;Oncologist,2011

2. Diagnosis and management of Castleman disease;Soumerai;Cancer Control,2014

3. Castleman disease;Dham;Curr Opin Hematol,2007

4. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma;Kaplan;Hematol Am Soc Hematol Educ Program,2013

5. New approaches to the treatment of human herpesvirus 8-associated disease;Casper;Rev Med Virol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis;Infection;2024-07-08

2. Human Herpesvirus-8 (HHV-8)-Positive Human Immunodeficiency Virus (HIV)-Negative Multicentric Castleman Disease With a Fulminant Course;Cureus;2024-02-17

3. Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment;New Drug Development for Known and Emerging Viruses;2021-12-03

4. Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease;International Journal of Hematology;2021-09-30

5. Recent Advances in Developing Treatments of Kaposi’s Sarcoma Herpesvirus-Related Diseases;Viruses;2021-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3